Artrite reumatoide, autocuidado e tratamento farmacológico: revisão de escopo
DOI:
https://doi.org/10.21527/2176-7114.2025.50.16251Palavras-chave:
Artrite Reumatoide, Autocuidado, Tratamento Farmacológico, Doenças Reumáticas, EnfermagemResumo
Objetivo: Sumarizar as evidências sobre o tratamento farmacológico e a relação com o autocuidado em indivíduos com artrite reumatoide. Método: Revisão de escopo realizada no primeiro semestre de 2023. Foram incluídos artigos a partir de 1985, publicados em periódicos indexados, literatura cinzenta e de listas de referências, não houve recorte idiomático. A seleção pelo software Rayyan e a coleta de dados em questionário padronizado no software Excel. O protocolo foi registrado no Open Science Framework doi.org/10.17605/OSF.IO/H3SZK. Resultados: Foram recuperados 31 estudos, entre o ano de 1999 a 2022, com predomínio de estudos transversais e publicados em inglês. Os fatores relacionados ao tratamento farmacológico e alteração no autocuidado que estiveram mais presentes nos estudos foram: efeitos colaterais da medicação, quantidade de medicamentos, tempo indeterminado de tratamento, automedicação, conhecimento do tratamento, efeitos positivos do tratamento, assim como o medo e as crenças negativas. Conclusão: A relação entre o autocuidado e o tratamento medicamentoso de indivíduos com artrite reumatoide envolve múltiplas variáveis e possivelmente uma abordagem individualizada possibilite a compreensão dos fatores de cada indivíduo e o manejo para a melhora do autocuidado.
Referências
1. Dedmon LE. The genetics of rheumatoid arthritis. Rheumatology (Oxford). 2020;59(10):2661-70. DOI: https://doi.org/10.1093/rheumatology/keaa232.
2. Roodenrijs NMT, Goes MC, Welsing PMJ, Tekstra J, Lafeber FPJG, Jacobs JWG, et al. Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology (Oxford). 2021;6(8):3778-88. DOI: https://doi.org/10.1093/rheumatology/keaa860.
3. Shi G, Liao X, Lin Z, Liu W, Luo X, Zhan H, et al. Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019. Clin Rheumatol. 2023;42(9):2297-2309. DOI: https://doi.org/10.1007/s10067-023-06628-2.
4. Simões TC, Meira KC, Santos J, Câmara DCP. Prevalence of chronic diseases and access to health services in Brazil: evidence of three household surveys. Ciênc. saúde coletiva. 2021;26(09):3991-4006. DOI: https://doi.org/10.1590/1413-81232021269.02982021.
5. Cush JJ. Rheumatoid Arthritis: Early Diagnosis and Treatment. Med Clin North Am. 2021;105(2):355-65. DOI: https://doi.org/10.1016/j.mcna.2020.10.006.
6. Orem DE, Taylor SG. Reflections on nursing practice science: the nature, the structure, and the foundation of nursing sciences. Nurs Sci Q. 2011;24(1):35-41. DOI: https://doi.org/10.1177/0894318410389061.
7. Yip JYC. Theory-Based Advanced Nursing Practice: A Practice Update on the Application of Orem's Self-Care Deficit Nursing Theory. SAGE Open Nurs. 2021;7:1-7. DOI: https://doi.org/10.1177/23779608211011993.
8. Papadimitropoulos E, Brnabic A, Vorstenbosch E, Leonardi F, Moyano S, Gomez D. The burden of illness of rheumatoid arthritis in Latin America-A systematic literature review. Int J Rheum Dis. 2022;25(4):405-21. DOI https://doi.org/10.1111/1756-185X.14295.
9. Nikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JWJ, Daien CI, et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis. 2021;80:1278-1285. DOI: http://dx.doi.org/10.1136/annrheumdis-2021-220249.
10. Damgaard AJ, Primdahl J, Esbensen BA, Latocha KM, Bremander A. Self-management support needs of patients with inflammatory arthritis and the content of self-management interventions: a scoping review. Semin Arthritis Rheum. 2023;60:152203. DOI: https://doi.org/10.1016/j.semarthrit.2023.152203.
11. Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid-Based Healthc. 2015;13(3):141–6. DOI: http://dx.doi.org/10.1097/XEB.0000000000000050.
12. Joanna Briggs Institute. JBI Levels of Evidence [Internet]. 2013 [cited 2023 aug 25]. Available from: https://jbi.global/sites/default/files/2019-05/JBI-Levels-of-evidence_2014_0.pdf.
13. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and Explanation. Ann Intern Med. 2018;169(7):467–73. DOI: http://dx.doi.org/10.7326/M18-0850.
14. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71). DOI: https://doi.org/10.1136/bmj.n71.
15. Gustafsson M, Gaston-Johansson F, Aschenbrenner D, Merboth M. Pain, coping and analgesic medication usage in rheumatoid arthritis patients. Patient Educ Couns. 1999;37(1):33-41. DOI: https://doi.org/10.1016/s0738-3991(98)00100-1.
16. Mishima M; Kunimoto, H; Yamasaki, K. A Survey on Self-Care of Rheumatoid Arthritis Patients. Shimane University Izumo Campus Bulletin. 1999;4:19-26. Available from: http://id.nii.ac.jp/1377/00000051/.
17. Magnusson CJ. The meaning of self-care for women with rheumatoid arthritis. Canada: The University of British Columbia; 2002 [cited 2023 may 20]. Available from: https://open.library.ubc.ca/media/stream/pdf/831/1.0055974/2.
18. Carder PC, Vuckovic N, Green CA. Negotiating medications: patient perceptions of long-term medication use. J Clin Pharm Ther. 2003;28(5):409-17. DOI: https://doi.org/10.1046/j.0269-4727.2003.00511.x.
19. Ahlmén M, Nordenskiöld U, Archenholtz B, Thyberg I, Rönnqvist R, Lindén L, et al. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology (Oxford). 2005;44(1):105-10. DOI: https://doi.org/10.1093/rheumatology/keh412.
20. Neame R, Hammond A, Deighton C. Need for information and for involvement in decision making among patients with rheumatoid arthritis: a questionnaire survey. Arthritis Rheum. 2005;53(2):249-55. DOI: https://doi.org/10.1002/art.21071.
21. Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford). 2005;44(6):762-7. DOI: https://doi.org/10.1093/rheumatology/keh587.
22. Pascual-Ramos V, Contreras-Yáñez I, Villa AR, Cabiedes J, Rull-Gabayet M. Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability. Arthritis Res Ther. 2009;11(1):R26. DOI: https://doi.org/10.1186/ar2620.
23. Lindén C, Björklund A. Living with rheumatoid arthritis and experiencing everyday life with TNF-α blockers. Scand J Occup Ther. 2010;17(4):326-34. DOI: https://doi.org/10.3109/11038120903480055.
24. Contreras-Yáñez I, León SP, Cabiedes J, Rull-Gabayet M, Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci. 2010;340(4):282-90. DOI: https://doi.org/10.1097/MAJ.0b013e3181e8bcb0.
25. Kett C, Flint J, Openshaw M, Raza K, Kumar K. Self-management strategies used during flares of rheumatoid arthritis in an ethnically diverse population. Musculoskeletal Care. 2010;8(4):204-14. DOI: https://doi.org/10.1002/msc.185.
26. Lempp H, Hofmann D, Hatch SL, Scott DL. Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative study. BMC Musculoskelet Disord. 2012;13:200. DOI: https://doi.org/10.1186/1471-2474-13-200.
27. Townsend A, Backman CL, Adam P, Li LC. A qualitative interview study: patient accounts of medication use in early rheumatoid arthritis from symptom onset to early postdiagnosis. BMJ Open. 2013;3(2):e002164. DOI: https://doi.org/10.1136/bmjopen-2012-002164.
28. Arvidsson S, Bergman S, Arvidsson B, Fridlund B, Tingström P. Effects of a self-care promoting problem-based learning programme in people with rheumatic diseases: a randomized controlled study. J Adv Nurs. 2013;69(7):1500-14. DOI: https://doi.org/10.1111/jan.12008.
29. Orefice D, Beauvais C, Gossec L, Flipon E, Fautrel B, Marguerie L, et al. Cross-sectional study of self-care safety skills in 677 patients on biodrugs for inflammatory joint disease. Joint Bone Spine. 2014;81(6):502-7. DOI: https://doi.org/10.1016/j.jbspin.2014.04.010.
30. Aikevičienė R. Quality of life, self–care and knowledge of chronic arthritis patients treated with biological therapy. Lithuania: Lithuanian University of Health Sciences; 2014 [cited 2023 may 21]. Available from: https://gs.elaba.lt/object/elaba:2214243/2214243.pdf.
31. Kordasiabi MC, Akhlaghi M, Baghianimoghadam MH, Morowatisharifabad MA, Askarishahi M, Enjezab B, et al. Self Management Behaviors in Rheumatoid Arthritis Patients and Associated Factors in Tehran 2013. Glob J Health Sci. 2015;8(3):156-67. DOI: https://doi.org/10.5539/gjhs.v8n3p156.
32. Meyfroidt S, van der Elst K, de Cock D, Joly J, Westhovens R, Hulscher M, et al. Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritis. Patient Educ Couns. 2015;98(3):384-90. DOI: https://doi.org/10.1016/j.pec.2014.11.011.
33. Zuidema RM, Repping-Wuts H, Evers AWM, Van Gaal BGI, Van Achterberg T. What do we know about rheumatoid arthritis patients’ support needs for self-management? A scoping review. Int J Nurs Stud. 2015;52(10):1617-1624. DOI: https://doi.org/10.1016/j.ijnurstu.2015.05.008.
34. Betegnie AL, Gauchet A, Lehmann A, Grange L, Roustit M, Baudrant M, et al.. Why Do Patients with Chronic Inflammatory Rheumatic Diseases Discontinue Their Biologics? An Assessment of Patients' Adherence Using a Self-report Questionnaire. J Rheumatol. 2016;43(4):724-30. DOI: https://doi.org/10.3899/jrheum.150414.
35. Bala SV, Samuelson K, Hagell P, Fridlund B, Forslind K, Svensson B, et al. Living with persistent rheumatoid arthritis: a BARFOT study. J Clin Nurs. 2017;26(17-18):2646-56. DOI: https://doi.org/10.1111/jocn.13691.
36. Elst K, Meyfroidt S, Cock D, Groef A, Binnard E, Moons P, et al. Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study. Arthritis Care Res (Hoboken). 2016;68(9):1278-87. DOI: https://doi.org/10.1002/acr.22824.
37. Poh LW, He HG, Chan WCS, Lee CSC, Lahiri M, Mak A, et al. Experiences of Patients With Rheumatoid Arthritis: A Qualitative Study. Clin Nurs Res. 2017;26(3):373-93. DOI: https://doi.org/10.1177/1054773816629897.
38. McBain H, Newman S, Shipley M, Olaleye A, Moore S. Experiences of a patient-initiated self-monitoring service in inflammatory arthritis: A qualitative exploration. Musculoskeletal Care. 2018;16(2):278-86. DOI: https://doi.org/10.1002/msc.1232.
39. Pedraz-Marcos A, Palmar-Santos AM, Hale CA, Zarco-Colón J, Ramasco-Gutiérrez M, García-Perea E, et al. Living With Rheumatoid Arthritis in Spain: A Qualitative Study of Patient Experience and the Role of Health Professionals. Clin Nurs Res. 2020;29(8):551-60. DOI: https://doi.org/10.1177/1054773818791096.
40. Landgren E, Bremander A, Lindqvist E, Nylander M, van der Elst K, Larsson I. "Mastering a New Life Situation" - Patients' Preferences of Treatment Outcomes in Early Rheumatoid Arthritis - A Longitudinal Qualitative Study. Patient Prefer Adherence. 2020;14:1421-33. DOI: https://doi.org/10.2147/PPA.S253507.
41. Cea-Calvo L, Marín-Jiménez I, Toro J, Fuster-RuizdeApodaca MJ, Fernández G, Sánchez-Vega N, et al. Association between non-adherence behaviors, patients' experience with healthcare and beliefs in medications: a survey of patients with different chronic conditions. Curr Med Res Opin. 2020;36(2):293-300. DOI: https://doi.org/10.1080/03007995.2019.1676539.
42. Ribeiro AA, Cunha M, Assis C, Nunes D, Fernandes L, Mariana M, et al. Fatores que Influenciam o Autocuidado nas Pessoas com Artrite Reumatóide: revisão integrativa da literatura. Millenium. 2020;2(5):293-303. DOI: https://doi.org/10.29352/mill0205e.31.00340.
43. Contreras-Yáñez I, Lavielle P, Clark P, Pascual-Ramos V. Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatients. Arthritis Res Ther. 2021;23(1):61. DOI: https://doi.org/10.1186/s13075-021-02440-y.
44. Voshaar MJH, van den Bemt BJF, van de Laar MAFJ, van Dulmen AM, Vriezekolk JE. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis. BMC Health Serv Res. 2022;22(1):62. DOI: https://doi.org/10.1186/s12913-021-07459-0.
45. Michou L, Julien AS, Witteman HO, Légaré J, Ratelle L, Godbout A, et al. Measuring the impact of an educational intervention in rheumatoid arthritis: An open-label, randomized trial. Arch Rheumatol. 2021;37(2):169-79. DOI: https://doi.org/10.46497/ArchRheumatol.2022.8965.
46. Gaud-Listrat V, Lopez-Medina C, Hudry C, Nguyen M, Lebrun-Foisnet A, Sacchi A, et al. Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study. Clin Exp Rheumatol. 2022;40(5):928-35. DOI: https://doi.org/10.55563/clinexprheumatol/slk3yz.
47. Wada M, Wallace JR. Designing technologies for self-care: Describing the lived experiences of individuals with rheumatoid arthritis. Human Factors in Healthcare. 2022;2:100025. DOI: https://doi.org/10.1016/j.hfh.2022.100025.
48. Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review. Eur J Med Chem. 2018;158:502-16. DOI: https://doi.org/10.1016/j.ejmech.2018.09.027.
49. Miyake H, Sada RM, Akebo H, Tsugihashi Y, Hatta K. Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study. Clin Rheumatol. 2023;42(9):2287-95. DOI: https://doi.org/10.1007/s10067-023-06646-0.
50. Kishimoto M, Yamairi F, Sato N, Kobayashi J, Yamauchi S, Iwasaki T. Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan. Rheumatol Ther. 2021;8(3):1095-111. DOI: https://doi.org/10.1007/s40744-021-00325-9.
51. Kuettel D, Primdahl J, Weber U, Terslev L, Østergaard M, Petersen R, et al. Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study. J Rheumatol. 2020;47(9):1305-13. DOI: https://doi.org/10.3899/jrheum.190760.
52. Jonge MJS, Weijers JM, Teerenstra S, Elwyn G, van de Laar MA, van Riel PL, et al. Patient involvement in rheumatoid arthritis care to improve disease activity-based management in daily practice: A randomized controlled trial. Patient Educ Couns. 2022;105(5):1244-53. DOI: https://doi.org/10.1016/j.pec.2021.08.013.
53. Palominos PE, Gasparin AA, Andrade NPB, Xavier RM, Chakr RMS, Igansi F, et al. Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review. Adv Rheumatol. 2018;58(1):1. DOI: https://doi.org/10.1186/s42358-018-0001-4.
54. Raghunath S, Hijjawi R, Hoon E, Shanahan EM, Goldblatt F. Avaliação qualitativa da adesão medicamentosa em pacientes com doenças reumáticas em terapia biológica. Clin Rheumatol. 2019;38(10):2699-707. DOI: https://doi.org/10.1007/s10067-019-04609-y.
55. Andreae C, Tingström P, Nilsson S, Jaarsma T, Karlsson N, Köhler AK. Does problem-based learning improve patient empowerment and cardiac risk factors in patients with coronary heart disease in a Swedish primary care setting? A long-term prospective, randomised, parallel single randomised trial (COR-PRIM). BMJ Open. 2023;13(2):e065230. DOI: https://doi.org/10.1136/bmjopen-2022-065230.
56. Marques A, Santos E, Nikiphorou E, Bosworth A, Carmonal L. Effectiveness of self-management interventions in inflammatory arthritis: a systematic review informing the 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. RMD Open. 2021;7(2):e001647. DOI: https://doi.org/10.1136/rmdopen-2021-001647.
57. Leonardo N, Lester S, Graham M, Barrett C, Whittle S, Rowett D, et al. Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. Int J Rheum Dis. 2020;23(6):805-12. DOI: https://doi.org/10.1111/1756-185X.13833.
58. Isik E, Fredland NM. Orem’s Self-Care Deficit Nursing Theory to Improve Children’s Self-Care: An Integrative Review. J Sch Nurs. 2023;39(1):6-17. DOI: https://doi.org/10.1177/10598405211050062.
59. Saeedifar ES, Memarian R, Fatahi S, Ghelichkhani F. Use of the Orem self-care model on pain relief in women with rheumatoid arthritis: a randomized trial. Electron Physician. 2018;10(6):6884-91. DOI: https://doi.org/10.19082/6884.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Revista Contexto & Saúde
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Autores que publicam na Revista Contexto & Saúde concordam com os seguintes termos:
a) A submissão de trabalho(s) científico(s) original(is) pelos autores, na qualidade de titulares do direito de autor do(s) texto(s) enviado(s) ao periódico, nos termos da Lei 9.610/98, implica na cessão de direitos autorais de publicação na Revista Contexto e Saúde do(s) artigo(s) aceitos para publicação à Universidade Regional do Noroeste do Estado do Rio Grande do Sul, autorizando-se, ainda, que o(s) trabalho(s) científico(s) aprovado(s) seja(m) divulgado(s) gratuitamente, sem qualquer tipo de ressarcimento a título de direitos autorais, por meio do site da revista e suas bases de dados de indexação e repositórios, para fins de leitura, impressão e/ou download do arquivo do texto, a partir da data de aceitação para fins de publicação. Isto significa que, ao procederem a submissão do(s) artigo(s) à Revista Contexto e Saúde e, por conseguinte, a cessão gratuita dos direitos autorais relacionados ao trabalho científico enviado, os autores têm plena ciência de que não serão remunerados pela publicação do(s) artigo(s) no periódico.
b). Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
c). Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
d). Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado (Veja O Efeito do Acesso Livre).
